Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) just unveiled an update.
ASKA Pharmaceutical Holdings Co., Ltd. announced the cancellation of 1,800,000 treasury shares, representing 5.89% of its issued shares, effective March 21, 2025. This move is part of the company’s strategic financial management, potentially impacting its share value and market perception by reducing the number of outstanding shares, which may benefit shareholders.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is headquartered in Minato-ku, Tokyo, and is led by President and Representative Director Takashi Yamaguchi.
YTD Price Performance: 7.91%
Average Trading Volume: 52,258
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: Yen64.35B
Find detailed analytics on 4886 stock on TipRanks’ Stock Analysis page.